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Candidalysin Is Required for Neutrophil Recruitment and 
Virulence During Systemic Candida albicans Infection
Marc Swidergall,1,2 Mina Khalaji,3,a Norma V. Solis,1,2 David L. Moyes,4 Rebecca A. Drummond,5,b Bernhard Hube,6,7 Michail S. Lionakis,5 Craig Murdoch,3 
Scott G. Filler,1,2,8 and Julian R. Naglik4
1Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California; 2Institute for Infection and Immunity, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 
Torrance, California; 3School of Clinical Dentistry, Claremont Crescent, University of Shefield, United Kingdom; 4Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial 
Sciences, King’s College London, United Kingdom; 5Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, Maryland; 6Department of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute), 
Jena, Germany; 7Friedrich Schiller University, Jena, Germany; 8David Geffen School of Medicine at UCLA, Los Angeles, California. 
Background. Candidalysin is a cytolytic peptide toxin secreted by Candida albicans hyphae and has signiicantly advanced our 
understanding of fungal pathogenesis. Candidalysin is critical for mucosal C albicans infections and is known to activate epithelial 
cells to induce downstream innate immune responses that are associated with protection or immunopathology during oral or vag-
inal infections. Furthermore, candidalysin activates the NLRP3 inlammasome and causes cytolysis in mononuclear phagocytes. 
However, the role of candidalysin in driving systemic infections is unknown.
Methods. In this study, using candidalysin-producing and candidalysin-deicient C albicans strains, we show that candidalysin 
activates mitogen-activated protein kinase (MAPK) signaling and chemokine secretion in endothelial cells in vitro.
Results. Candidalysin induces immune activation and neutrophil recruitment in vivo, and it promotes mortality in zebraish 
and murine models of systemic fungal infection.
Conclusions. he data demonstrate a key role for candidalysin in neutrophil recruitment and fungal virulence during dissem-
inated systemic C albicans infections.
Keywords. Candida albicans; candidalysin; fungal; systemic; endothelial.
Fungal infections affect one quarter of the world’s population 
and kill ~1.5 million people each year, surpassing the numbers 
killed by either malaria, breast cancer, or prostate cancer [1]. 
One of the most medically important fungi is Candida albicans, 
which causes millions of mucosal infections and contributes 
to ~400 000 life-threatening systemic infections annually [1–
3]. Despite these alarmingly high figures, it is unclear how C 
albicans drives mortality during these disseminated systemic 
infections.
During hematogenously disseminated candidiasis (HDC), C 
albicans must irst cross the endothelial lining of the blood vessels 
at the site of infection [4]. Once in the bloodstream, C albicans 
is disseminated throughout the host where the fungus must 
again cross the endothelial lining before colonizing the major 
organs. As such, the endothelium functions as an integral com-
ponent of the host defence system to recognize and respond to 
C albicans during systemic infections. One potential mechanism 
by which C albicans crosses the endothelial lining is via induced 
endocytosis, which is a hypha-dependent process [5]. Candida 
albicans hyphae are endocytosed by numerous human endothe-
lial cells including umbilical, dermal microvascular, and brain 
microvascular endothelial cells [6–9]. Endothelial cells respond 
to C albicans hyphae via the activation of signaling pathways, in-
cluding the stress-activated p38 mitogen-activated protein kinase 
(MAPK) pathway [10], and the secretion of proinlammatory 
mediators such as CXCL8 (interleukin [IL]-8), tumor necrosis 
factor (TNF)α, IL-1α, and IL-1β [10, 11]. Transcript proiling ex-
periments indicated that overrepresented genes included those 
for neutrophil recruitment and signal transduction [10]. Hypha 
formation is critical for the initiation of these endothelial cell 
responses because hyphal-defective C albicans strains (such as 
cph1∆/efg1∆) were unable to induce strong proinlammatory 
responses [12]. hus, endothelial cells respond to C albicans 
hyphae through the production of proinlammatory cytokines, 
which may facilitate clearance through active recruitment of im-
mune cells to the site of infection. Likewise, hyphae are known 
to trigger pyroptosis and the NLRP3 inlammasome in mononu-
clear phagocytes [13, 14].
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A key pathogenic trait of C albicans is its ability to induce cell 
damage. Candida albicans-driven damage of epithelial cells and 
macrophages is mediated by the peptide toxin, candidalysin 
[13, 15–18]. Candida albicans candidalysin is generated from its 
parent protein (Ece1p) via sequential enzymatic processing by 
Kex2/1 and secreted from hyphae [19]. Candidalysin is amphi-
pathic, adopts an α-helical structure, and permeabilizes mem-
branes, resulting in the release of lactate dehydrogenase [15], 
which is a characteristic of cell damage and membrane destabi-
lization. Candidalysin activates epithelial proinlammatory re-
sponses via 2 MAPK signaling pathways (p38/c-Fos and MEK/
ERK/MKP1) [20–23], which induce downstream immune re-
sponses including neutrophil recruitment and innate Type-17 
immunity, which are critical for protection against oral and vag-
inal candidiasis [15, 16, 24–26]. Furthermore, candidalysin is 
the hyphal moiety that activates the NLRP3 inlammasome and 
causes cytolysis in mononuclear phagocytes [13].
Currently, the role of candidalysin in driving systemic 
C albicans infections is unknown. Given that expression of 
candidalysin is hypha-associated and induces damage, signaling 
and proinlammatory responses in epithelial cells [18, 27–30], 
and the NLRP3 inlammasome in macrophages [13], we inves-
tigated whether candidalysin drives endothelial cell activation, 
immune cell recruitment, and mortality during systemic infec-
tions. We found that candidalysin activates MAPK signaling 
and cytokine responses in endothelial cells and promotes neu-
trophil recruitment and mortality during zebraish and murine 
models of systemic C albicans infection.
METHODS
Candida albicans Strains
Candida albicans strains used in this study are BWP17+CIp30 
(wild-type), ece1Δ/Δ (ECE1-deficient), ece1Δ/Δ+ECE1 (ECE1 
revertant), and ece1Δ/Δ+ECE1Δ 
184–279
 (candidalysin-deficient) 
as previously described [15].
Endothelial Cell Culture and Candida albicans Infection
Human adult dermal microvascular endothelial cells 
([HDMECs] PromoCell GmbH) were cultured in supple-
mented MV endothelial cell growth medium (PromoCell 
GmbH). The immortalized human microvascular endothelial 
cell line, HMEC-1 (provided by Ades et al [31]), were cultured 
as described [32]. Cells were incubated at 37°C in 5% CO
2
 and 
transferred to antibiotic and hydrocortisone-free medium. The 
HDMECs or HMEC-1 (1 × 106) were cultured for 24 hours and 
then transferred to serum and antibiotic-free media (SFM) for 
18 hours. Candida albicans strains were cultured in yeast pep-
tone dextrose (YPD) broth (Oxoid) overnight at 25°C, washed 
with phosphate-buffered saline (PBS), and resuspended in SFM. 
For signaling experiments, C albicans was added to the endothe-
lial cells in SFM (multiplicity of infection [MOI] of 10) and in-
cubated for 2 hours, otherwise endothelial cells were incubated 
with an MOI of 0.1 for 24 hours; in both instances, infections 
were carried out at 37°C in 5% CO
2
. Conditioned medium from 
endothelial cells was collected, centrifuged, and stored at −20°C.
Cell Lysate Preparation and Immunoblotting
The HMEC-1 cells were washed with ice-cold PBS, lysed with 
100 μL ice-cold Radio-Immunoprecipitation Assay (Sigma-
Aldrich) buffer containing phosphatase and protease inhibitors 
(Pierce) on ice for 15 minutes, and then centrifuged at 10 000 ×g 
at 4°C for 10 minutes. Total protein concentration was analyzed 
by bicinchoninic acid assay (Pierce). Forty micrograms of total 
protein of each sample was separated by 10% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis, proteins were trans-
ferred to a nitrocellulose membrane (iBlot; Invitrogen), and 
immunoblot analysis was performed as previously described 
[15]. Membranes were incubated with primary antibody: rabbit 
anti-phospho-MEK1/2 (clone 41G9), anti-phospho-p44/42 
(ERK1/2) (clone D13.14.4E), anti-phospho-c-Jun (clone 54B3), 
anti-c-Fos (clone 9F6) (Cell Signaling Technology) at 4°C 
overnight, followed by horse radish peroxidase-conjugated 
secondary antibody and developed by enhanced chemilumi-
nescence. β-actin was used as the housekeeping gene (Sigma).
Lactate Dehydrogenase Release and Cytokine and Chemokine Analysis
Endothelial cell damage was analyzed by measuring the release 
of lactate dehydrogenase (LDH) into the culture medium using 
a CytoTox96 assay kit (Promega). The concentration of CXCL8 
within conditioned medium was measured by CXCL8 enzyme-
linked immunosorbent assay ([ELISA]; BD Biosciences). For 
murine studies, kidney homogenates were clarified by centrif-
ugation, and the concentrations of cytokines and chemokines 
were measured using a multiplex bead array (R&D Systems) 
as previously described [33]. Myeloperoxidase (MPO) protein 
levels in kidney homogenates were determined using ELISA, 
following the manufacturer’s instructions (Hycult Biotech).
Zebrafish Candida albicans Infection Model
Zebrafish maintenance and experimental work was performed 
in accordance with UK Home Office regulations and the UK 
Animals (Scientific Procedures) Act 1986. London wild-type 
zebrafish larvae were maintained as previously described [34]. 
For infection, methylcellulose-embedded, tricaine-anesthetized 
dechorionated larvae were injected systemically by direct inoc-
ulation into the common cardinal vein at 2 days postfertilization 
with 500 colony-forming units of C albicans in PBS or PBS 
alone as control (n = 20 zebrafish injected per treatment group). 
Zebrafish viability was assessed by presence of a heartbeat at 24 
hours postinfection.
Mouse Model of Hematogenously Disseminated Candidiasis 
Animal work was approved by the Institutional Animal Care 
and Use Committee of the Los Angeles Biomedical Research 
Institute. Virulence of the C albicans strains was tested in the 
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mouse model of HDC using 6- to 7-week-old male and female 
BALB/c mice (Taconics) as previously described [35]. In some 
mice, leukopenia was induced by intravenous administration 
of 5 mg of 5-fluorouracil (Western Medical) on day −1 rela-
tive to infection. Enrofloxacin (Victor Medical) was added to 
the drinking water of these mice to prevent bacterial infection. 
Candida albicans strains were serially passaged 3 times in YPD 
broth, grown at 30°C at 200 rpm for 16–24 hours at each pas-
sage. Yeast cells were washed in PBS, renumerated, and injected 
intravenously via the lateral tail vein. Immunocompetent and 
leukopenic mice were infected by injecting 2 × 105 and 5 × 104 
C albicans cells, respectively. Each C albicans strain was inocu-
lated into 10 mice (5 male/5 female). Animals were randomly 
assigned to the different groups. Researchers were not blinded 
to the experimental groups because the endpoints (survival, 
fungal burden, cytokine levels) were objective measures of dis-
ease severity. For survival experiments, mice were monitored 
twice daily and moribund mice were humanely euthanized. 
To determine organ fungal burden, mice were sacrificed after 
1 day and 4 days of infection, after which the kidneys, brain, 
spleen, and liver were harvested, weighed, homogenized, and 
quantified on YPD. For histology, mouse kidneys were fixed in 
10% buffered formalin and embedded in paraffin. Thin sections 
were cut and stained with Grocott-Gomori methenamine silver 
stain and imaged by light microscopy.
Statistics
Data are presented as mean values ± standard deviation of at 
least 3 independent experiments with each test performed in 
triplicate unless otherwise stated. Mann-Whitney, log rank, or 
analysis of variance multiple statistical comparisons were per-
formed with Tukey’s post hoc comparison using GraphPad 
Prism, version 6.00. Differences between test and control 
groups were considered significant when P < .05.
RESULTS
Candidalysin Damages and Induces Immune Activation in Endothelial 
Cells
One mechanism by which candidalysin may facilitate C 
albicans translocation across the endothelial cell lining to in-
itiate disseminated infection is via the induction of damage. 
Therefore, we determined whether candidalysin was able to 
induce LDH release in 2 endothelial cell types. The HDMEC 
and HMEC-1 cells were incubated with candidalysin-
producing (BWP17+CIp30 [wild-type], ece1Δ/Δ+ECE1) and 
candidalysin-deficient (ece1Δ/Δ; encoding candidalysin) C 
albicans strains, and LDH release was measured after 24 hours. 
Only candidalysin-producing C albicans strains were able to in-
duce LDH release from both endothelial cell types (Figure 1A), 
indicating that candidalysin induces damage. However, in the 
HMEC-1 cell line, the ece1Δ/Δ mutant was still able to induce a 
modest amount of damage.
Candidalysin induces cytokine release in epithelial cells and 
macrophages [13, 15–19, 24, 28, 30]. herefore, we tested whether 
candidalysin could also induce cytokine release in HDMEC and 
HMEC-1 cells. CXCL8 was used as a marker for immune activa-
tion because this chemokine is released from endothelial cells in 
response to C albicans [10, 11]. We found that only candidalysin-
producing C albicans strains were able to induce CXCL8 release 
(Figure 1B), demonstrating that candidalysin is a critical acti-
vator of immune responses in endothelial cells.
Epithelial cells respond to candidalysin activity via the in-
duction of MAPK signaling. Two key proteins that are acti-
vated are the AP-1 transcription factor c-Fos (via p38) and the 
MAPK phosphatase MKP1 (via MEK1/2-ERK1/2) [20–23]. To 
determine whether candidalysin induces MAPK signaling in 
endothelial cells, we incubated HMEC-1 cells with C albicans 
strains and tested for c-Fos upregulation and phosphorylation 
of MEK1/2 and ERK1/2 at 2 hours (previously determined as 
the optimum time [20]). We additionally tested for the phos-
phorylation of another AP-1 transcription factor, c-Jun, because 
this can be activated by JNK (third arm of the MAPK pathway) 
and can form a heterodimer with c-Fos to activate gene ex-
pression. Only candidalysin-producing C albicans strains 
strongly induced c-Fos, phospho-c-Jun, phospho-MEK1/2, and 
phospho-ERK1/2 in HMEC-1 cells (Figure 1C), indicating that 
candidalysin is critical for MAPK activation in endothelial cells.
Candidalysin Is Required for Virulence in a Zebrafish Model of Candida 
albicans Systemic Infection
The ability of candidalysin to damage and induce MAPK-
mediated immune responses in endothelial cells may enhance the 
ability of C albicans to translocate across the endothelial lining 
and promote systemic infection, similar to C albicans transloca-
tion across epithelial layers [17]. Furthermore, these activities may 
be associated with protective or detrimental immune responses 
[16, 24]. To determine whether candidalysin was required for 
systemic infection, we first utilized a zebrafish model to screen 
the virulence potential of the C albicans strains. Zebrafish larvae 
were infected with C albicans strains in the common cardinal 
vein, and survival was monitored for 24 hours. Although ~35% of 
fish survived when infected with candidalysin-producing strains, 
significantly more (~80%) fish survived when infected with a 
candidalysin-deficient (ece1Δ/Δ) strain (Figure 2A). Histological 
analysis showed extensive hyphal network formation in fish in-
fected with the candidalysin-producing strains along with wide-
spread tissue destruction and edema. In contrast, in fish infected 
with the candidalysin-deficient strain, fewer hyphae were present 
with limited associated tissue damage (Figure 2B). In a control 
experiment, a C albicans strain deficient in the hypha-associated 
adhesin/invasion ALS3 (als3 Δ/Δ) was equally as virulent as the 
wild-type (Figure 2A). The data indicate that candidalysin pro-
motes infection and a deleterious phenotype in this zebrafish sys-
temic model.
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Figure 1. Candidalysin induces cell damage, cytokine release, and intracellular signaling in human endothelial cells. Cell damage (A) and CXCL8 (B) chemokine release 
quantiied by lactate dehydrogenase assay and enzyme-linked immunosorbent assay, respectively, for human microvascular endothelial cell line (HMEC-1) and human adult 
dermal microvascular endothelial cells (HDMECs) after exposure to wild-type, ece1∆/∆ , or ece1∆/∆+ECE1 Candida albicans (multiplicity of infection [MOI] of 0.1) for 24 
hours; medium alone was used as uninfected control. Data are presented as mean ± standard deviation (n = 3); statistical analysis was achieved using one-way analysis of 
variance with Tukey’s post hoc multiple comparison test. *, P < .05; **, P < .01; and ***, P < .001. (C) Immunoblot analysis of HMEC-1 intracellular signaling responses to 
wild-type, ece1∆/∆, ece1∆/∆+ECE1 C albicans (MOI of 10) or control for 2 hours. The HMEC-1 cell lysates (40 μg of total protein) were probed with c-Fos, phospho-c-Jun, 
phospho-ERK1/2, or phospho-MEK1/2, and β-actin was used as a loading control.
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Candidalysin Is Required for Neutrophil Recruitment and Virulence in a 
Murine Model of Disseminated Candida albicans Infection
The zebrafish screen demonstrated the importance of 
candidalysin in promoting C albicans-mediated infection. 
Therefore, we progressed to determine whether candidalysin 
was also required for systemic infection in a murine model 
of disseminated candidiasis. For these experiments, we in-
cluded an additional C albicans strain deficient solely in the 
candidalysin-encoding region of ECE1 (ece1Δ/Δ+ECE1
Δ184–279
). 
Animals were infected with C albicans strains, and fungal 
burden, tissue invasion, cytokine production, and survival were 
monitored over time. Fungal burdens were monitored at day 
1 and 4 postinfection in the spleen, brain, kidney, and liver 
(Figure 3). Also of note, at day 1, there was a significant increase 
in burdens in the spleen, brain, and kidney of animals infected 
with both candidalysin-deficient C albicans strains (ece1Δ/Δ, 
ece1Δ/Δ+ECE1
Δ184–279
) in comparison with the wild-type strain 
(BWP17+CIp30). A significant increase in burdens was also ob-
served in the spleen and kidney of animals infected with the 
ECE1 revertant strain (ece1Δ/Δ+ECE1). By day 4, there were no 
differences in burdens between the C albicans strains, except for 
in the brain, where burdens remained high in animals infected 
with candidalysin-deficient C albicans strains (2 logs greater 
than wild-type). There was no difference in burdens between C 
albicans strains on day 1 or 4 in the liver.
Given that the main diferences in fungal burdens be-
tween the C albicans strains was at day 1, we assessed the 
proinlammatory response in kidney homogenates at this 
time point (Figure 4). In comparison to wild-type C albicans, 
the ECE1-deicient strain (ece1Δ/Δ) induced signiicantly de-
creased levels of CCL2, CCL3, CCL4, CXCL1, IL-1α, S100A8, 
and TNFα, which was mirrored by the candidalysin-deicient 
strain (ece1Δ/Δ+ECE1
Δ184–279
) for CCL3, CCL4, and CXCL1. 
However, although not always statistically signiicant, there 
was a clear trend of reduced secretion of all cytokines, except 
interferon-γ, with ece1Δ/Δ+ECE1
Δ184–279
. Also of note, all cy-
tokine responses recovered to wild-type levels with the ece1Δ/
Δ+ECE1 revertant strain. he data indicate that candidalysin 
is a key driver of proinlammatory responses during systemic 
infection.
he key role of candidalysin in damaging and inducing 
neutrophil-recruiting chemokines (eg, CXCL1, CXCL8) in 
mice and human endothelial cells prompted us to analyze 
the invasion and neutrophil recruitment capabilities of the C 
albicans strains by histology. All C albicans strains were able 
to form hyphae and invaded the kidney at day 1 postinfection 
(Figure 5A and B). However, only the candidalysin-producing 
strains induced strong neutrophil accumulation to the infection 
site. At later time points during hematogenously disseminated 
candidiasis, inlammatory processes spread to the renal tubules 
and pelvis with marked neutrophil accumulation, which can 
mediate tissue damage [36, 37]. herefore, we compared the 
ability of the wild-type and ece1Δ/Δ C albicans strains to ex-
tend to the pelvis region of the kidney and cause renal pelvis 
injury at day 4 postinfection (Figure 5C) when similar fungal 
burdens were observed (Figure 3B). Only wild-type C albicans 
was able to invade the pelvis region, with concomitant neu-
trophil accumulation and associated local immunopathology, 
whereas ece1Δ/Δ was unable to invade the pelvis region and re-
mained in the renal cortex (Figure 5C). he increased ability 
of candidalysin-producing C albicans strains to recruit neutro-
phils was conirmed by the increased production of MPO in 
kidney homogenates (Figure 5D). he data indicate that during 
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buffered saline (PBS) as control directly into the cardinal vein. Data are presented 
as mean ± standard deviation (n = 4 independent experiments with at least 20 
zebraish per treatment group); statistical analysis was achieved using one-way 
analysis of variance with Tukey’s post hoc multiple comparison test. **, P < .01; and 
***, P < .001. (B) Sagittal histological sections of periodic acid-Schiff-stained in-
fected zebraish showing the hyphal form of C albicans penetrating zebraish tissue 
for wild-type, ece1Δ/Δ and ece1Δ/Δ+ECE1 strains compared with PBS-injected 
controls. Scale bars = 100 μm.
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Figure 3. Absence of candidalysin increases organ-speciic tropism during hematogenously disseminated candidiasis. Fungal burden of the spleen, brain, kidney, and liver 
of mice at 1 day (A) and 4 days (B) postinfection after inoculation with 2 × 105 Candida albicans cells of the indicated strains. Results are median ± interquartile range of 2 
independent experiments with 10 mice per strain at each time point. Statistical signiicance is indicated by **, P < .01 and ****, P < .0001 (Mann-Whitney test with Bonferroni 
correction for multiple comparisons). Dashed line indicates limit of detection in the liver. CFU, colony-forming units.
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systemic infection, candidalysin promotes C albicans invasion 
and is a potent mediator of neutrophil recruitment to the in-
fection site.
he diferences in the capacity of candidalysin-producing and 
-deicient C albicans strains to induce cytokines and neutrophil 
accumulation suggest that candidalysin plays a key role in driving 
systemic infection. herefore, we undertook survival experi-
ments and conirmed that candidalysin-producing strains were 
more pathogenic than candidalysin-deicient strains. Animals 
infected with candidalysin-producing strains all succumbed by 
day 10 (25% survival at day 7), whereas animals infected with 
candidalysin-deicient strains succumbed by day 14 (100% sur-
vival at day 7) (Figure 6A). Given the important function of 
candidalysin in mediating neutrophil recruitment, we next de-
pleted animals of neutrophils using 5-luorouracil and assessed 
the virulence capacity of the wild-type and ece1Δ/Δ C albicans 
strains. Under these conditions, both C albicans strains became 
equally virulent and all mice succumbed to infection by day 7 
(Figure 6B), despite fungal burdens being signiicantly higher 
in all organs infected with C albicans ece1Δ/Δ (Figure 6C). As 
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Figure 4. Candidalysin is required to induce an early antifungal immune response in the kidney. Level of chemokines and cytokines in kidney homogenates of immuno-
competent mice with hematogenously disseminated candidiasis after 1 day of infection with 2 × 105 Candida albicans cells of the indicated strains. Results are median ± 
interquartile range of 2 independent experiments with 10 mice per strain. Statistical signiicance is indicated by *, P < .05, **, P < .01, and ****, P < .0001 (Mann-Whitney 
test with Bonferroni correction for multiple comparisons).
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previously shown, C albicans ece1Δ/Δ was unable to invade the 
pelvis region and remained in the renal cortex (Figure 6D). hese 
data, taken together, suggest that candidalysin production during 
systemic infections induces local proinlammatory and chemo-
tactic responses, which function to recruit neutrophils to the in-
fection site, thereby promoting pathogenicity and disease.
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Figure 5. Candidalysin is required for renal neutrophil recruitment and immunopathology. (A and B) Histopathology of the kidney of mice after 1 day of infection with 2 × 105 
Candida albicans cells of the indicated strains. Sections (A, low magniication; B, high magniication) were stained with Gomori methenamine silver (GMS). Fungal cells are 
ilamentous and stained black, and polymorphonuclear (PMN) cells are round and dark purple. Scale bar = 50 µm. (C) Histopathology of the pelvis region (top and middle) and 
renal cortex (bottom) of the mouse kidney 4 days postinfection with 2 × 105 C albicans cells of the indicated strains. Sections were stained with GMS. Fungal cells are ilamen-
tous and stained black, and PMN cells are round and purple surrounding fungal ilaments. Only wild-type C albicans invades the pelvis region with local immunopathology, 
whereas the ece1Δ/Δ remains in the renal cortex. Scale bar = 200 µm. (D) Myeloperoxidase (MPO) expression in kidney homogenates after 1 day of infection with 2 × 105 C 
albicans cells of the indicated strains. Results are median ± interquartile range of 2 independent experiments with 10 mice per strain. Statistical signiicance is indicated by 
****, P < .0001 (Mann-Whitney test with Bonferroni correction for multiple comparisons).
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Figure 6. Candidalysin-induced immunopathology is required for virulence during hematogenously disseminated candidiasis. (A) Survival of immunocompetent mice after 
intravenous inoculation with 2 × 105 yeast phase cells of the indicated strains of Candida albicans (n = 10). (B) Survival of leukopenic mice infected with 5 × 104 wild-type 
or ece1Δ/Δ C albicans yeast. Statistical signiicance is indicated by **, P < .01 (wild-type vs ece1Δ/Δ) and ****, P < .0001 (ece1Δ/Δ+ECE1 vs ece1Δ/Δ+ECE1Δ184–279) 
(Wilcoxon rank-sum test). (C) Fungal burden of the kidney, brain, spleen, and liver of leukopenic mice at 4 days postinfection after inoculation with 5 × 104 wild-type or 
ece1Δ/Δ C albicans yeast. Results are median ± interquartile range with 6 mice per strain. Statistical signiicance is indicated by **, P < .01 (Mann-Whitney test). (D) 
Histopathology of the pelvis region (top, lower magniication; bottom, higher magniication) of the kidney of leukopenic mice after 4 days of infection with 5 × 104 C albicans 
cells of the indicated strains. Sections were stained with Gomori methenamine silver. Scale bars = 200 µm. CFU, colony-forming units.
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DISCUSSION
The discovery of candidalysin, the first peptide toxin identified 
in any human fungal pathogen, has provided a significant ad-
vance in our understanding of C albicans pathogenesis [15, 18, 
27–30]. Candidalysin is produced by hyphae and is critically 
important for promoting mucosal C albicans infections [15–17, 
19, 24, 25]. Although candidalysin activates the inflammasome 
in macrophages [13], its role in promoting systemic C albicans 
infection was hitherto unknown. In this study, we demon-
strate that candidalysin promotes virulence during systemic C 
albicans infections with a key role in mediating neutrophil ac-
cumulation in infected renal tissue.
We irst investigated the ability of candidalysin to damage and 
activate endothelial cells, which may facilitate C albicans trans-
location across the blood vessel lining to establish a hematoge-
nous disseminated infection. Candidalysin damaged endothelial 
cells and induced MAPK signaling via MEK1/2 and ERK1/2, 
resulting in the activation of the AP-1 transcription factors, 
c-Fos and c-jun, and the secretion of the neutrophil-recruiting 
chemokine CXCL8. Although candidalysin activates similar 
MAPK/c-Fos-mediated pathways in oral [15, 19, 24] and vaginal 
[16] epithelial cells, the induction of the MAPK/c-jun pathway 
appears speciic to endothelial cells. Given that CXCL8 expres-
sion is mediated by c-jun/AP-1 in endothelial cells [38], the data 
indicate that candidalysin activates c-jun/AP-1 to upregulate 
CXCL8 secretion. herefore, although both endothelial and ep-
ithelial cells respond to candidalysin in a similar fashion, some 
cell-speciic diferences are observable. However, we note that 
these experiments were undertaken in vitro and acknowledge 
that evidence for a direct efect of candidalysin on endothelial 
cell activation events in vivo is limited from these studies.
In previous studies, 2 other fungal proteins, Ssa1p and Als3p, 
were shown to mediate C albicans endocytosis in endothelial cells 
via N-cadherin [6, 7, 39]. Although immune activation mechan-
isms by Ssa1 has not been investigated, Als3p does not induce 
MAPK/c-Fos signaling or cytokine release in oral epithelial cells 
[40] and is dispensable for virulence in murine [41] and zebraish 
(this work) models of disseminated candidiasis. herefore, al-
though C albicans possesses multiple hypha-associated factors to 
promote virulence, candidalysin appears to be the critical factor 
inducing endothelial cell damage and proinlammatory cyto-
kines that recruit and activate phagocytes, such as neutrophils.
In both zebraish and murine infection models, candidalysin-
producing strains were signiicantly more lethal than 
candidalysin-deicient C albicans strains. he increase in mor-
tality directly correlated with immune activation, because only 
candidalysin-producing strains induced strong cytokine/che-
mokine secretion, particularly those associated with immune 
cell (notably neutrophil) recruitment (CCL2/3/4, CXCL1, 
S100A8). Histological and ELISA (MPO) analyses conirmed 
that only candidalysin-producing strains were able to induce 
prominent neutrophil accumulation to the kidney at day 1 
postinfection, at a time point when neutrophils are protective 
[42, 43]. In agreement with the early protective efect of neu-
trophils, mice infected with wild-type C albicans had reduced 
fungal burdens at this time point. In contrast, neutrophils exert 
detrimental efects in this model at later stages of infection, 
and part of this immunopathogenic response is driven by the 
CCL3-CCR1 chemokine axis [37, 44]. Also of note, only wild-
type C albicans invaded the pelvic region of the kidney at day 4, 
which correlated with signiicant neutrophil accumulation and 
associated tissue injury, despite the presence of similar fungal 
burdens in the mouse kidneys infected with the ECE1-deicient 
C albicans strain. Instead, infection with candidalysin-deicient 
strains resulted in decreased CCL3 levels, the ligand for CCR1, 
and decreased renal pelvis damage and neutrophil-mediated 
immunopathology. Given that candidalysin is known to pro-
mote C albicans translocation across the gut barrier [17], the 
data support the notion that candidalysin may also facilitate 
C albicans invasion through parenchymal organs during sys-
temic infections. Our data correlate (1) with previous data in 
the systemic candidiasis model indicating that CCR1-mediated 
neutrophil recruitment at later infection time points can be 
detrimental [37, 44] and (2) with mucosal infection studies 
demonstrating that neutrophil recruitment to the site of infec-
tion is candidalysin-dependent [15, 16, 24].
he dual role of candidalysin in promoting infection while 
concurrently inducing neutrophil responses was conirmed in 
neutrophil-depletion experiments, where both candidalysin-
producing and -deicient C albicans strains became equally vir-
ulent. It is interesting to note that the signiicantly higher fungal 
burdens in all organs of leukopenic animals infected with C 
albicans ece1Δ/Δ suggest that candidalysin activity and immune 
cell activation, but not fungal burdens, are the critical factors 
in determining morbidity and mortality during systemic infec-
tions. he indings are clinically relevant because neutropenic 
patients are highly susceptible to disseminated candidiasis [3, 
45]. As such, the data inextricably link (1) candidalysin activity 
with C albicans pathogenicity and (2) neutrophil activation with 
disease outcome.
As mentioned above, it is intriguing that mortality and im-
mune activation did not correlate with increased fungal bur-
dens. his was most notable in the brain, where signiicantly 
more fungal burdens were observed with candidalysin-deicient 
strains. hese striking diferences in fungal burdens were re-
cently found to be due to candidalysin-dependent induction 
of IL-1β and CXCL1 secretion from CARD9+ microglial cells, 
which function to recruit CXCR2-expressing neutrophils to the 
brain to control the infection and hence reduce fungal burdens 
[46]. his inding, together with the fact that candidalysin-
deicient strains produce normal hyphae [15], may challenge 
the long-held view that C albicans pathogenicity in systemic in-
fections directly correlates with increased fungal burdens and 
hypha formation. Indeed, in certain tissues (ie, brain), the data 
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appear to uncouple pathogenicity from hypha formation and 
correlate pathogenicity with the ability of C albicans to damage 
and induce strong local immune responses, predominantly 
through candidalysin activity and neutrophil recruitment.
CONCLUSIONS
The data, taken together, suggest that during disseminated candi-
diasis, candidalysin production by C albicans hyphae stimulates 
a strong proinflammatory response with neutrophil recruitment, 
which reduces fungal burdens during early infection but later 
hastens mortality likely related to immunopathogenic effects. In 
contrast, in the absence of candidalysin, there is a reduced inflam-
matory response with a lack of neutrophil recruitment, which 
promotes C albicans proliferation during early infection but also 
prolongs survival, enabling the fungus to traffic to and survive in 
the brain. In summary, the data demonstrate that candidalysin 
production during disseminated systemic infections promotes 
virulence, neutrophil recruitment, and disease and may identify 
candidalysin-associated damage and immune activation path-
ways as novel targets to combat disseminated fungal infections.
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